MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
Integra LifeSciences Holdings Corporation Cash and Cash Equivalents 2011-2026 | IART
Annual Cash and Cash Equivalents Integra LifeSciences Holdings Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 246 M | 276 M | 457 M | 513 M | 470 M | 199 M | 139 M | 175 M | 102 M | 48.1 M | 71.7 M | 121 M | 96.9 M | 101 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 513 M | 48.1 M | 215 M |
Quarterly Cash and Cash Equivalents Integra LifeSciences Holdings Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 218 M | 239 M | 215 M | 215 M | 592 M | 274 M | 309 M | 307 M | 457 M | 512 M | 447 M | 407 M | 513 M | 470 M | 397 M | 409 M | 470 M | 470 M | 470 M | 470 M | 199 M | 199 M | 199 M | 199 M | 139 M | 139 M | 139 M | 139 M | 175 M | 175 M | 175 M | 175 M | 102 M | 102 M | 102 M | 102 M | 48.1 M | 48.1 M | 48.1 M | 48.1 M | 71.7 M | 71.7 M | 72 M | 72 M | 121 M | 121 M | 121 M | 121 M | 96.9 M | 96.9 M | 96.9 M | 96.9 M | 101 M | 101 M | 101 M | 101 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 592 M | 48.1 M | 216 M |
Cash and Cash Equivalents of other stocks in the Medical devices industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Axonics Modulation Technologies
AXNX
|
239 M | - | - | $ 3.31 B |  USA |
 |
Helius Medical Technologies
HSDT
|
5.18 M | $ 2.01 | -6.94 % | $ 1.22 M | USA |
 |
Aziyo Biologics
AZYO
|
36.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
19.2 M | - | -26.83 % | $ 2.62 M | USA |
 |
BioSig Technologies
BSGM
|
142 K | - | 37.08 % | $ 85.7 M | USA |
 |
Allied Healthcare Products
AHPI
|
3.32 M | - | 3.58 % | $ 2.21 M | USA |
 |
Conformis
CFMS
|
48.7 M | - | - | $ 16.4 M | USA |
 |
Delcath Systems
DCTH
|
43.5 M | $ 9.12 | -0.87 % | $ 327 M | USA |
 |
Dynatronics Corporation
DYNT
|
326 K | - | 14.99 % | $ 929 K | USA |
 |
Cardiovascular Systems
CSII
|
66.4 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
18.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
57 M | - | - | $ 475 M | USA |
 |
Outset Medical
OM
|
35 M | $ 3.49 | -1.13 % | $ 53.1 K | USA |
 |
Avinger
AVGR
|
5.28 M | - | -20.74 % | $ 369 K | USA |
 |
Sintx Technologies
SINT
|
4.14 M | $ 2.41 | -5.82 % | $ 6.68 M | USA |
 |
CONMED Corporation
CNMD
|
40.8 M | $ 36.24 | -2.27 % | $ 1.12 B | USA |
 |
Electromed
ELMD
|
15.3 M | $ 24.5 | -0.65 % | $ 207 M | USA |
 |
Neovasc
NVCN
|
51.5 M | - | - | $ 111 M |  Canada |
 |
Cytosorbents Corporation
CTSO
|
3.28 M | $ 0.61 | -9.13 % | $ 33.2 M | USA |
 |
Aethlon Medical
AEMD
|
5.5 M | $ 2.37 | 2.16 % | $ 3.7 M | USA |
 |
Sensus Healthcare
SRTS
|
22.1 M | $ 4.04 | -4.38 % | $ 66 M | USA |
 |
BIOLASE
BIOL
|
6.57 M | - | -13.19 % | $ 166 K | USA |
 |
Smith & Nephew plc
SNN
|
619 M | $ 32.28 | -0.52 % | $ 23.8 B |  Britain |
 |
LivaNova PLC
LIVN
|
636 M | $ 64.3 | 1.58 % | $ 3.51 B | Britain |
 |
InspireMD
NSPR
|
8.94 M | $ 1.73 | -1.14 % | $ 111 M |  Israel |
 |
AdaptHealth Corp.
AHCO
|
106 M | $ 11.32 | -0.61 % | $ 1.53 B | USA |
 |
Penumbra
PEN
|
187 M | $ 337.62 | 0.4 % | $ 13.1 B | USA |
 |
Stryker Corporation
SYK
|
4.01 B | $ 333.54 | 1.83 % | $ 127 B | USA |
 |
MiMedx Group
MDXG
|
166 M | $ 3.98 | -3.05 % | $ 588 M | USA |
 |
TELA Bio
TELA
|
50.8 M | $ 0.73 | 5.78 % | $ 34.3 M | USA |
 |
Invacare Corporation
IVC
|
58.8 M | - | - | $ 24.7 M | USA |
 |
Myomo
MYO
|
14.1 M | $ 0.68 | -2.34 % | $ 28.5 M | USA |
 |
NanoVibronix
NAOV
|
752 K | - | - | $ 1.08 M | USA |
 |
Tandem Diabetes Care
TNDM
|
90.6 M | $ 23.13 | -4.66 % | $ 1.57 B | USA |
 |
Inspire Medical Systems
INSP
|
105 M | $ 50.84 | -1.11 % | $ 1.49 B | USA |
 |
Pulmonx Corporation
LUNG
|
69.8 M | $ 1.29 | -0.77 % | $ 52.5 M | USA |
 |
Cutera
CUTR
|
144 M | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
NuVasive
NUVA
|
249 M | - | - | $ 2.07 B | USA |